Trond is professor of medicinal chemistry at the University of Copenhagen and the University of Southern Denmark. He received his dr. ing. degree from the Norwegian University of Technology and Science in 1999. Thereafter, he was postdoc at the Scripps Research Institute before joining the Danish startup company 7TM Pharma in 2001. In 2005, he moved to the University of Southern Denmark to establish his independent academic research group. His research interests include medicinal chemistry, drug discovery and development of synthetic methods with potential use in these areas. In January 2018, he joined the University of Copenhagen.
Elisabeth is assistant professor funded by the Lundbeck Fondation and leads a project directed towards the short-chain fatty acid receptor FFA3, a collaboration with the University of Copenhagen and the University of Glasgow. She also leads the medicinal chemistry part of a project on the succinate receptor GPR91 that is based at the University of Copenhagen. Elisabeth is also interested in development of fluorescent tool compounds. She received her PhD from the University of Southern Denmark in 2012
Nassos’ PhD project is focused on elucidating the roles of the free fatty acid receptors FFA1 and FFA4 in the CNS, including development of brain penetrant specific FFA1 and FFA4 modulators and tools to evaluate the exposure of the brain to dietary fatty acid. He received his MSc degree in pharmaceutical sciences from the University of Copenhagen in 2017.
Mads’ PhD project is within the FFARMED project and involves synthesis of fatty acid derivatives and development of ligands for the receptor GPR84. He has his MSc degree from the University of Southern Denmark.
Bharat received his PhD from the University of Southern Denmark in 2014. He has a MSc degree from the Pune University and worked for 5 years at Albany Molecular Research in Singapore before moving to Denmark. His PhD and postdoc work has focused primarily on the free fatty acid receptor FFA4. For the most recent 2 years, he has worked with Caldan Therapeutics.
Matjaz received his PhD from the University of Ljubliana in 2012 on structure-based design of DNA gyrage B inhibitors. He was a researcher at the National Institute of Chemistry in Ljulibana, Slovenia, before moving to the University of Southern Denmark as postdoc and lab manager in 2016.
Dmitrii received his PhD from the University of Münster in 2016. He joined the group as a postdoc in 2017. His main project is on development of methods for synthesis of receptor ligands.
Jan received his PhD from the University of Southern Denmark in 2017 on a collaborative project with the Griffith University, Australia, on discovery of new AMPK modulators. He has his MSc from the Zürich University of Applied Sciences in 2014.
Henriette Blicher Christensen
Henriettes MSc-project is focused on development of improved modulators of the short-chain fatty acid receptor FFA2.
Camilla Kurth Ehlers
Camilla’s project is aimed at development of FFA2 modulators.
Julie’s project is aimed at development of FFA2 modulators.
Christoffer Vogsen Heidtmann
Christoffer’s project is aimed at development of GPR84 modulators.
Marija’s project is aimed at development of GPR84 modulators.
Anders Møller Kirketerp
Lone Overgaard Storm